Work

ILF2-YB1 Protein Interaction Modulates RNA Splicing to Induce Resistance to Chemotherapy in High Risk Multiple Myeloma

Year: 2016

Type: article

Source: Blood

DOI: 10.1182/blood.v128.22.359.359

Authors: Matteo Marchesini, Yamini Ogoti, Elena Fiorini, Marianna D'anca, Paola Storti, Luigi Nezi, Mehmet K. Samur, Irene Gañán-Gómez, Mariateresa Fulciniti, Zachary S. Bohannan, Karen Clise-Dwyer, Nicola Giuliani, Nikhil C Munshi, Robert Z. Orlowski, Guillermo Garcia-Manero, Ronald A. DePinho, Simona Colla

Institutions: The University of Texas MD Anderson Cancer Center, University of Parma, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2587071122

FWCI:

Cites:

Cited by:

Related to: 10